There is no so-called “special effect drug” for AML. Acute myeloid leukemia is one kind of acute leukemia, which can be divided into many subtypes, including m0~m7 subtypes, among which m3 type (acute promyelocytic leukemia) has the best therapeutic effect at present, which is mainly treated with all-trans retinoic acid combined with arsenic agent. For other subtypes of leukemia, there is generally no specific drug, mainly through chemotherapy drugs combined with hematopoietic stem cell transplantation, targeted drugs such as Vinacrine. It is recommended to consult a doctor in time and choose the appropriate drugs and methods for treatment under the doctor’s guidance.